Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score

• Elliot B. Tapper ,

  * E-mail: etapper@bidmc.harvard.edu

  Affiliation Division of Gastroenterology/Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States of America

  ⨯
• M. G. Myriam Hunink,

  Affiliations Dept of Radiology, Dept of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands, Center for Health Decision Sciences, Harvard T.H. Chan School of Public Health, Boston, United States of America

  ⨯
• Nezam H. Afdhal,

  Affiliation Division of Gastroenterology/Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States of America

  ⨯
• Michelle Lai,

  Affiliation Division of Gastroenterology/Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States of America

  ⨯
• Neil Sengupta

  Affiliation Division of Gastroenterology/Hepatology/Nutrition, Department of Medicine, University of Chicago, Chicago, Illinois

  ⨯